EUR 58.46
(-0.51%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 7.28 Billion EUR | -2.44% |
2022 | 7.46 Billion EUR | -4.43% |
2021 | 7.8 Billion EUR | 7.27% |
2020 | 7.28 Billion EUR | 16.22% |
2019 | 6.26 Billion EUR | 9.72% |
2018 | 5.7 Billion EUR | -4.47% |
2017 | 5.97 Billion EUR | -0.7% |
2016 | 6.01 Billion EUR | -13.02% |
2015 | 6.91 Billion EUR | -19.59% |
2014 | 8.6 Billion EUR | 17.01% |
2013 | 7.35 Billion EUR | -6.75% |
2012 | 7.88 Billion EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 7.29 Billion EUR | 3.01% |
2024 Q1 | 7.08 Billion EUR | -2.71% |
2024 Q3 | 7.19 Billion EUR | -1.4% |
2023 Q4 | 7.28 Billion EUR | 1.51% |
2023 FY | 7.28 Billion EUR | -2.44% |
2023 Q1 | 7.55 Billion EUR | 1.25% |
2023 Q2 | 7.41 Billion EUR | -1.85% |
2023 Q3 | 7.17 Billion EUR | -3.28% |
2022 Q3 | 7.52 Billion EUR | -1.4% |
2022 Q2 | 7.62 Billion EUR | 0.14% |
2022 FY | 7.46 Billion EUR | -4.43% |
2022 Q1 | 7.61 Billion EUR | -2.46% |
2022 Q4 | 7.46 Billion EUR | -0.77% |
2021 Q1 | 7.29 Billion EUR | 0.19% |
2021 Q3 | 7.87 Billion EUR | 8.9% |
2021 Q4 | 7.8 Billion EUR | -0.89% |
2021 FY | 7.8 Billion EUR | 7.27% |
2021 Q2 | 7.23 Billion EUR | -0.81% |
2020 Q4 | 7.28 Billion EUR | 2.25% |
2020 FY | 7.28 Billion EUR | 16.22% |
2020 Q2 | 7.23 Billion EUR | 13.79% |
2020 Q3 | 7.12 Billion EUR | -1.59% |
2020 Q1 | 6.35 Billion EUR | 1.5% |
2019 Q3 | 6.35 Billion EUR | -1.58% |
2019 FY | 6.26 Billion EUR | 9.72% |
2019 Q4 | 6.26 Billion EUR | -1.42% |
2019 Q1 | 6.42 Billion EUR | 12.59% |
2019 Q2 | 6.45 Billion EUR | 0.44% |
2018 Q2 | 5.39 Billion EUR | -3.21% |
2018 Q3 | 5.48 Billion EUR | 1.56% |
2018 Q4 | 5.7 Billion EUR | 4.16% |
2018 FY | 5.7 Billion EUR | -4.47% |
2018 Q1 | 5.57 Billion EUR | -6.69% |
2017 Q1 | 6.06 Billion EUR | 0.75% |
2017 FY | 5.97 Billion EUR | -0.7% |
2017 Q4 | 5.97 Billion EUR | 2.52% |
2017 Q3 | 5.82 Billion EUR | 0.95% |
2017 Q2 | 5.77 Billion EUR | -4.77% |
2016 Q2 | 6.69 Billion EUR | -10.68% |
2016 Q4 | 6.01 Billion EUR | -11.51% |
2016 Q3 | 6.8 Billion EUR | 1.54% |
2016 Q1 | 7.49 Billion EUR | 8.38% |
2016 FY | 6.01 Billion EUR | -13.02% |
2015 Q2 | 9.06 Billion EUR | 0.0% |
2015 Q3 | 9.7 Billion EUR | 7.15% |
2015 Q4 | 6.91 Billion EUR | -28.74% |
2015 Q1 | - EUR | -100.0% |
2015 FY | 6.91 Billion EUR | -19.59% |
2014 FY | 8.6 Billion EUR | 17.01% |
2014 Q1 | - EUR | 0.0% |
2014 Q4 | 8.6 Billion EUR | 0.0% |
2013 FY | 7.35 Billion EUR | -6.75% |
2012 FY | 7.88 Billion EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AlzChem Group AG | 261.11 Million EUR | -2688.395% |
L'Air Liquide S.A. | 23.28 Billion EUR | 68.737% |
Brenntag SE | 5.98 Billion EUR | -21.733% |
Evonik Industries AG | 12.27 Billion EUR | 40.694% |
Fuchs Petrolub SE | 619 Million EUR | -1076.252% |
Fuchs Petrolub SE | 619 Million EUR | -1076.252% |
LANXESS Aktiengesellschaft | 5.8 Billion EUR | -25.362% |
Masterflex SE | 36.68 Million EUR | -19746.267% |
Nabaltec AG | 144.36 Million EUR | -4943.571% |
Symrise AG | 4.33 Billion EUR | -67.81% |
Uzin Utz AG | 162.71 Million EUR | -4374.805% |
VERBIO Vereinigte BioEnergie AG | 449.53 Million EUR | -1519.659% |
Wacker Chemie AG | 4.42 Billion EUR | -64.483% |